Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency

Highly specialised technologies guidance
Reference number: HST26
Published: 19 April 2023

History

Expected publication

Register of interests (PDF 181 KB)

Published:

19 April 2023
Equality Impact Assessment (Guidance development) (PDF 141 KB)

Published:

19 April 2023

Final evaluation determination

Final evaluation determination
Committee papers (PDF 11.64 MB)

Published:

23 March 2023
Final evaluation determination document (PDF 274 KB)

Published:

23 March 2023
Public committee slides (PDF 1.17 MB)

Published:

23 March 2023

Invitation to participate

Final stakeholder list (PDF 157 KB)

Published:

07 March 2022
Equality impact assessment (Scoping) (PDF 120 KB)

Published:

07 March 2022
Final scope (PDF 174 KB)

Published:

07 March 2022
Draft scope and provisional stakeholder list comments table (post-referral) (PDF 383 KB)

Published:

07 March 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 175 KB)

Published:

01 July 2021
Draft matrix post referral (PDF 157 KB)

Published:

01 July 2021